Philip Zorn, DO - Medicare Emergency Medicine in Red Wing, MN

Philip Zorn, DO is a medicare enrolled "Emergency Medicine" physician in Red Wing, Minnesota. His current practice location is 701 Hewitt Blvd, Red Wing, Minnesota. You can reach out to his office (for appointments etc.) via phone at (651) 267-5000.

Philip Zorn is licensed to practice in Minnesota (license number 65575) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1447600556.

Contact Information

Philip Zorn, DO
701 Hewitt Blvd,
Red Wing, MN 55066
(651) 267-5000
(651) 267-5964



Physician's Profile

Full NamePhilip Zorn
GenderMale
SpecialityEmergency Medicine
Location701 Hewitt Blvd, Red Wing, Minnesota
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1447600556
  • Provider Enumeration Date: 06/20/2016
  • Last Update Date: 07/18/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0345534178
  • Enrollment ID: I20190722001396

Medical Identifiers

Medical identifiers for Philip Zorn such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447600556NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 65575 (Minnesota)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Philip Zorn allows following entities to bill medicare on his behalf.
Entity NameMayo Clinic Health System-lake City
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164463659
PECOS PAC ID: 1951213487
Enrollment ID: O20031104000095

News Archive

Covidien releases results from largest global post-market P.A.D. device study

Covidien, a leading global provider of healthcare products, today released the six-month results of the DEFINITIVE LE (Determination of Effectiveness of SilverHawk Peripheral Plaque Excision System for the Treatment of Infrainguinal Vessels/Lower Extremities) study, the largest global post-market peripheral arterial disease (P.A.D.) device study ever undertaken.

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

Inhibiting cholesterol esterification can potentiate antitumor activity of killer T cells

As key players in the immune system, T cells provide tumor surveillance and have direct antitumor effects. However, tumors can escape T-cell attack through various mechanisms in the tumor microenvironment. Reactivating the antitumor effects of T cells has shown great clinical benefits in treating various cancers.

Sheer scale of bushfire devastation revealed as death toll rises

As Australians come to terms with the sheer scale of the destruction from the fires in Victoria, on an almost hourly basis the grisly search for survivors uncovers more victims.

Read more Medical News

› Verified 7 days ago

Entity NameMayo Clinic Health System-southeast Minnesota Region
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1891701637
PECOS PAC ID: 4385556703
Enrollment ID: O20031104000408

News Archive

Covidien releases results from largest global post-market P.A.D. device study

Covidien, a leading global provider of healthcare products, today released the six-month results of the DEFINITIVE LE (Determination of Effectiveness of SilverHawk Peripheral Plaque Excision System for the Treatment of Infrainguinal Vessels/Lower Extremities) study, the largest global post-market peripheral arterial disease (P.A.D.) device study ever undertaken.

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

Inhibiting cholesterol esterification can potentiate antitumor activity of killer T cells

As key players in the immune system, T cells provide tumor surveillance and have direct antitumor effects. However, tumors can escape T-cell attack through various mechanisms in the tumor microenvironment. Reactivating the antitumor effects of T cells has shown great clinical benefits in treating various cancers.

Sheer scale of bushfire devastation revealed as death toll rises

As Australians come to terms with the sheer scale of the destruction from the fires in Victoria, on an almost hourly basis the grisly search for survivors uncovers more victims.

Read more Medical News

› Verified 7 days ago

Entity NameMayo Clinic Health System-lake City
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1538113022
PECOS PAC ID: 1951213487
Enrollment ID: O20070711000490

News Archive

Covidien releases results from largest global post-market P.A.D. device study

Covidien, a leading global provider of healthcare products, today released the six-month results of the DEFINITIVE LE (Determination of Effectiveness of SilverHawk Peripheral Plaque Excision System for the Treatment of Infrainguinal Vessels/Lower Extremities) study, the largest global post-market peripheral arterial disease (P.A.D.) device study ever undertaken.

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

Inhibiting cholesterol esterification can potentiate antitumor activity of killer T cells

As key players in the immune system, T cells provide tumor surveillance and have direct antitumor effects. However, tumors can escape T-cell attack through various mechanisms in the tumor microenvironment. Reactivating the antitumor effects of T cells has shown great clinical benefits in treating various cancers.

Sheer scale of bushfire devastation revealed as death toll rises

As Australians come to terms with the sheer scale of the destruction from the fires in Victoria, on an almost hourly basis the grisly search for survivors uncovers more victims.

Read more Medical News

› Verified 7 days ago

Entity NameMayo Clinic Health System-southeast Minnesota Region
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1063435410
PECOS PAC ID: 4385556703
Enrollment ID: O20171011003946

News Archive

Covidien releases results from largest global post-market P.A.D. device study

Covidien, a leading global provider of healthcare products, today released the six-month results of the DEFINITIVE LE (Determination of Effectiveness of SilverHawk Peripheral Plaque Excision System for the Treatment of Infrainguinal Vessels/Lower Extremities) study, the largest global post-market peripheral arterial disease (P.A.D.) device study ever undertaken.

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

Inhibiting cholesterol esterification can potentiate antitumor activity of killer T cells

As key players in the immune system, T cells provide tumor surveillance and have direct antitumor effects. However, tumors can escape T-cell attack through various mechanisms in the tumor microenvironment. Reactivating the antitumor effects of T cells has shown great clinical benefits in treating various cancers.

Sheer scale of bushfire devastation revealed as death toll rises

As Australians come to terms with the sheer scale of the destruction from the fires in Victoria, on an almost hourly basis the grisly search for survivors uncovers more victims.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Philip Zorn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Philip Zorn, DO
200 1st St Sw,
Rochester, MN 55905-0001

Ph: (651) 267-5000
Philip Zorn, DO
701 Hewitt Blvd,
Red Wing, MN 55066

Ph: (651) 267-5000

News Archive

Covidien releases results from largest global post-market P.A.D. device study

Covidien, a leading global provider of healthcare products, today released the six-month results of the DEFINITIVE LE (Determination of Effectiveness of SilverHawk Peripheral Plaque Excision System for the Treatment of Infrainguinal Vessels/Lower Extremities) study, the largest global post-market peripheral arterial disease (P.A.D.) device study ever undertaken.

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

Inhibiting cholesterol esterification can potentiate antitumor activity of killer T cells

As key players in the immune system, T cells provide tumor surveillance and have direct antitumor effects. However, tumors can escape T-cell attack through various mechanisms in the tumor microenvironment. Reactivating the antitumor effects of T cells has shown great clinical benefits in treating various cancers.

Sheer scale of bushfire devastation revealed as death toll rises

As Australians come to terms with the sheer scale of the destruction from the fires in Victoria, on an almost hourly basis the grisly search for survivors uncovers more victims.

Read more News

› Verified 7 days ago


Emergency Medicine Doctors in Red Wing, MN

Gregory A Kays, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066
Phone: 651-267-5000    
John V Politsch, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066
Phone: 651-267-5000    
Alfred Gerald Campo, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 701 Fairview Blvd, Red Wing, MN 55066
Phone: 651-267-5050    
Julie Rossi Polonczyk, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066
Phone: 651-267-5000    
Dr. Ryan Patrick Kelly,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066
Phone: 651-267-5000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.